GlassScriptPhysician profile
Mohammad S Siddiqui
NPI 1659481414
$4,823.15
in general payments reported to CMS, 2019-2025
13 companies · $76.62 in 2025
The $76.62 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $125 · 2021: $151 · 2022: $608 · 2023: $3,350 · 2024: $262 · 2025: $76.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $751 · Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $751.09 |
| Food and Beverage | $438.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,016.81 | 2022-2024 | Davinci Xi, Da Vinci Sp, Da Vinci Surgical System |
| Janssen Pharmaceuticals, INC | $192.74 | 2020-2023 | Xarelto |
| Prytime Medical Devices, INC. | $145.56 | 2019 | |
| Alexion Pharmaceuticals, INC. | $135.77 | 2021 | |
| Depuy Synthes Sales INC. | $104.97 | 2019 | |
| Abiomed | $55.98 | 2024 | Impella |
| Endologix LLC | $55.25 | 2025 | Torus Stent Graft System, Endocross Device |
| Smith+Nephew, INC. | $31.14 | 2021-2022 | |
| Ethicon US, LLC | $21.37 | 2025 | Ethicon, Stratafix, Dermabond |
| Lilly USA, LLC | $18.40 | 2023 | Jardiance |
| Olympus America INC. | $16.32 | 2023 | Olympus |
| Medtronic, INC. | $15.56 | 2022 | |
| Lemaitre Vascular, INC. | $13.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.